Analysed BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) News Sources
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
07-04-2026
yahoo.com
BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy
30-03-2026
yahoo.com
BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
24-03-2026
yahoo.com
BioNxt Signs Strategic Agreement for Eurasian Commercialization Following Cladribine ODF Patent Grant in Eurasia and Europe
17-03-2026
yahoo.com
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
17-02-2026
yahoo.com
BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
05-02-2026
yahoo.com
BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
26-01-2026
yahoo.com
What is the current price of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?
The current price of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is $0.3243.
BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) since the previous trading day is $-0.015.
BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) since the previous trading day is -4.4209%.
What is the most recent average sentiment score for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?
The most recent average sentiment score for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?
The most recent sentiment for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is .
SEC-8K** Filing Available For BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.